Showing results (1-10 of 300) with videos related to
Sort By:
Pageof 30
Frontiers in Oncology|November 25, 2022
Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyondChristopher W Mangieri, Edward A LevineAnnals of Surgical Oncology|February 4, 2025
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen, et al.Surgery|November 16, 2020
Quality analysis of operative reports and referral data for appendiceal neoplasms with peritoneal disseminationChristopher W Mangieri, Omeed Moaven, Konstantinos I Votanopoulos, et al.Annals of Surgical Oncology|August 29, 2021
Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal ChemotherapyChristopher W Mangieri, Cristian D Valenzuela, Richard A Erali, et al.Journal of Surgical Oncology|November 29, 2021
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgeryChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.Annals of Surgical Oncology|January 13, 2022
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.Journal of Surgical Oncology|October 26, 2022
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.Annals of Surgical Oncology|December 9, 2022
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.Annals of Surgical Oncology|August 15, 2022
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.Annals of Surgical Oncology|March 7, 2022
Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous NeoplasmsCristian D Valenzuela, Christopher W Mangieri, Mary Garland-Kledzik, et al.Pageof 30